Skip to main content
SpringerLink
Log in

Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and agalsidase alpha in cultured fibroblasts from patients with Fabry disease

  • Letter to the Editors
  • Published:
Journal of Inherited Metabolic Disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Porto C, Pisani A, Rosa M et al (2012) Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease. J Inher Metab Dis 35:513–520

    Article  CAS  PubMed  Google Scholar 

  • Porto C, Cardone M, Fontana F et al (2009) The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts. Mol Ther 17:964–971

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Telethon Foundation (Grant TGPMT4TELD).

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Public Health, Section of Nephrology, University of Naples Federico II, Naples, Italy

    Antonio Pisani

  2. Telethon Institute of Genetics and Medicine, Via P. Castellino 111, 80131, Naples, Italy

    Caterina Porto & Giancarlo Parenti

  3. Department of Translational Medical Sciences, Section of Pediatrics, Federico II University, Via S. Pansini 5, 80131, Naples, Italy

    Caterina Porto, Generoso Andria & Giancarlo Parenti

Authors
  1. Antonio Pisani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caterina Porto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Generoso Andria
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giancarlo Parenti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giancarlo Parenti.

Additional information

Communicated by: Maurizio Scarpa

Antonio Pisani and Caterina Porto contributed equally to the work and are listed in alphabetical order

Electronic supplementary material

Below is the link to the electronic supplementary material.

Fig. S1

(JPEG 438 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pisani, A., Porto, C., Andria, G. et al. Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and agalsidase alpha in cultured fibroblasts from patients with Fabry disease. J Inherit Metab Dis 37, 145–146 (2014). https://doi.org/10.1007/s10545-013-9641-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-013-9641-z

Keywords

Search

Navigation